PrEP Assistance Program Act
Sponsored By: Representative Watson Coleman, Bonnie [D-NJ-12]
Introduced
Summary
Expands access to HIV prevention by funding local PrEP programs and creating a reimbursement pathway so uninsured people can get PrEP and related care at no cost. This law creates two linked programs to grow PrEP delivery and pay providers for HIV prevention services.
Personalized for You
How does this bill affect your finances?
Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Bill Overview
Analyzed Economic Effects
3 provisions identified: 3 benefits, 0 costs, 0 mixed.
Grants to expand local PrEP access
If enacted, the bill would create federal grants to fund local PrEP programs. The HHS Secretary would set up the grant program within one year of enactment. The bill would authorize $400 million per year for each of FY2027 through FY2031 and would cap any single grant at $10 million. Grantees would usually need to provide a 10% match, but the Secretary could waive that match for certain safety-net clinics; programs could not charge people for services paid with grant funds. HHS would publish eligible expenses and must report to Congress each year for the first five years with disaggregated data.
PrEP Pass for uninsured people
If enacted, the bill would create a federal provider reimbursement program so uninsured people can get PrEP drugs, required tests, and related services at no cost. The HHS Secretary would set payment rates for covered items and review them at least every two years. The program would issue a "PrEP Pass" card or other technology so registered providers accept program payments and agree not to bill uninsured patients for covered services. Clinical diagnostic lab tests covered under Medicare Part B would be reimbursed at the same rates as Medicare clinical laboratory payments.
Who can run PrEP programs
If enacted, the bill would define terms used across the PrEP programs. Eligible entities would include states, local and tribal governments, federally qualified health centers, rural health clinics, community groups, hospital clinics, and university clinics. The bill would define "PrEP medication" as any FDA‑approved drug to prevent HIV and would treat U.S. territories as "States" for program purposes.
Sponsors & CoSponsors
Sponsor
Watson Coleman, Bonnie [D-NJ-12]
NJ • D
Cosponsors
Carson
IN • D
Sponsored 2/4/2026
Rep. Waters, Maxine [D-CA-43]
CA • D
Sponsored 2/4/2026
Rep. Tlaib, Rashida [D-MI-12]
MI • D
Sponsored 2/4/2026
Sewell
AL • D
Sponsored 2/4/2026
Rep. Pocan, Mark [D-WI-2]
WI • D
Sponsored 2/4/2026
Del. Norton, Eleanor Holmes [D-DC-At Large]
DC • D
Sponsored 2/4/2026
Rep. Moore, Gwen [D-WI-4]
WI • D
Sponsored 2/4/2026
Davis (IL)
IL • D
Sponsored 2/4/2026
Keating
MA • D
Sponsored 2/4/2026
Thompson (MS)
MS • D
Sponsored 2/4/2026
Rep. Ansari, Yassamin [D-AZ-3]
AZ • D
Sponsored 2/4/2026
Rep. Kelly, Robin L. [D-IL-2]
IL • D
Sponsored 2/4/2026
Cohen
TN • D
Sponsored 2/20/2026
Rep. Johnson, Julie [D-TX-32]
TX • D
Sponsored 4/16/2026
Roll Call Votes
No roll call votes available for this bill.
View on Congress.gov